Aedo-Lopez, V.; Gérard, C.L.; Boughdad, S.; Gautron Moura, B.; Berthod, G.; Digklia, A.; Homicsko, K.; Schaefer, N.; Duran, R.; Cuendet, M.A.;
et al. Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma. Cancers 2022, 14, 1162.
https://doi.org/10.3390/cancers14051162
AMA Style
Aedo-Lopez V, Gérard CL, Boughdad S, Gautron Moura B, Berthod G, Digklia A, Homicsko K, Schaefer N, Duran R, Cuendet MA,
et al. Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma. Cancers. 2022; 14(5):1162.
https://doi.org/10.3390/cancers14051162
Chicago/Turabian Style
Aedo-Lopez, Veronica, Camille L. Gérard, Sarah Boughdad, Bianca Gautron Moura, Gregoire Berthod, Antonia Digklia, Krisztian Homicsko, Niklaus Schaefer, Rafael Duran, Michel A. Cuendet,
and et al. 2022. "Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma" Cancers 14, no. 5: 1162.
https://doi.org/10.3390/cancers14051162
APA Style
Aedo-Lopez, V., Gérard, C. L., Boughdad, S., Gautron Moura, B., Berthod, G., Digklia, A., Homicsko, K., Schaefer, N., Duran, R., Cuendet, M. A., & Michielin, O.
(2022). Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma. Cancers, 14(5), 1162.
https://doi.org/10.3390/cancers14051162
